Medical Treatment in Endometriosis

Elham Pourmatroud
In: Endometriosis - Basic Concepts and Current Research Trends · 2012 · doi:10.5772/29932 · W1527886003
OA: hybrid CC0 ⤵ 4 in-corpus citations
🔓 Open OA copy Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-06 ⓘ

Common endometriosis medications suppress ovulation and have teratogenic effects, but may preserve fertility by reducing disease activity and preventing new implants, though other methods are ultimately needed for pregnancy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-27 · read from full text ⓘ

This chapter provides a comprehensive overview of the medical management strategies available for treating endometriosis, focusing on hormonal therapies that suppress ovarian function. It reviews various pharmacological options including oral contraceptives, progestins, and gonadotropin-releasing hormone agonists, evaluating their efficacy in reducing pain and lesion size while considering side effect profiles. The text highlights the importance of individualized treatment plans based on patient symptoms, desire for fertility, and response to previous therapies. This paper is centrally about endometriosis — specifically detailing the spectrum of medical treatments used to manage the condition.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

It must to keep in mind that those common administrated drugs couldn’t help to restore the fertility potentials and in fact during their usage pregnancy cannot or should not be happened, regarding to inhibition of ovulation or teratogenic effects; of course by their administration with remission of disease (suppress the growth and activity of previous endometriotic implants) and reducing the chance of new peritoneal seeding, fertility may be preserved better; but at the end for achieving pregnancy other ways should be used.
Full text 531 characters · extracted from oa-doi-fallback · click to expand
Open access Submitted: 13 March 2011 Published: 09 May 2012 DOI: 10.5772/29932 From the Edited Volume Edited by Koel Chaudhury and Baidyanath Chakravarty Submitted: 13 March 2011 Published: 09 May 2012 © 2012 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Discover 2026 Nobel Laureate Francis Halzen’s chapter on IntechOpen >

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (53)

Cited by (4)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK